⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5159191 | 0.84 | KMT2A (0.45) | — | |
| SCHEMBL13937956 | 0.75 | — | — | |
| SCHEMBL28064327 | 0.74 | — | — | |
| SCHEMBL3679547 | 0.73 | — | — | |
| SCHEMBL5449927 | 0.69 | KMT2A (0.41) | — | |
| SCHEMBL5276093 | 0.65 | MAPK1 (0.31) | — | |
| SCHEMBL6141334 | 0.65 | — | — | |
| SCHEMBL7629878 | 0.65 | — | — | |
| SCHEMBL1975714 | 0.64 | — | — | |
| SCHEMBL16010715 | 0.63 | SERPINE1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054527-A1 | Administration of capsaicinoids | ALGORX (US) | 2009-02-26 | — | — | US | claimed |
| EP-1587506-A4 | ADMINISTRATION OF CAPSAICINOIDS | ALGORX (US) | 2006-05-24 | — | — | EP | claimed |
| EP-1587506-A2 | ADMINISTRATION OF CAPSAICINOIDS | Algorx (US) | 2005-10-26 | — | — | EP | claimed |
| US-20040156931-A1 | Administration of capsaicinoids | ALGORX | 2004-08-12 | — | — | US | claimed |
| WO-2004056305-A2 | ADMINISTRATION OF CAPSAICINOIDS | ALGORX (US) | 2004-07-08 | — | — | WO | claimed |
| US-5646181-A | ORGANIC NITRITE COMPOUNDS | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1997-07-08 | — | — | US | claimed |
| US-5489610-A | TREATING CONDITIONS SUCH AS ANGINA PECTORIS, ISCHEMIC DISEASES, CONGESTIVE HEART FAILURE, CONTROLLING HYPERTENSION AND IMPOTENCE IN MALE PATIENTS | RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) | 1996-02-06 | — | — | US | claimed |
| EP-0604642-A1 | SUSTAINED RELEASE ORGANIC NITRITE THERAPY | BAKER NORTON PHARMACEUTICALS, INC. (US) | 1994-07-06 | — | — | EP | claimed |
| WO-1994001103-A1 | SUSTAINED RELEASE ORGANIC NITRITE THERAPY | BAKER NORTON PHARMACEUTICALS, INC. (US) | 1994-01-20 | — | — | WO | claimed |
| US-20090117167-A1 | Injectable capsaicin with vasocontrictor adjunctive agent | ALGORX (US) | 2009-05-07 | — | — | US | disclosed |
| US-20090118242-A1 | Injectable capsaicin with non-steroidal anti-inflammatory adjunctive agent | ALGORX (US) | 2009-05-07 | — | — | US | disclosed |
| US-20090111792-A1 | Injectable capsaicin with tricyclic antidepressant adjunctive agent | ALGORX (US) | 2009-04-30 | — | — | US | disclosed |
| US-20090062359-A1 | Injectable capsaicin with non-local anesthetic sodium channel-blocker adjunctive agent | ALGORX (US) | 2009-03-05 | — | — | US | disclosed |
| US-20090054527-A1 | Administration of capsaicinoids | ALGORX (US) | 2009-02-26 | — | — | US | disclosed |
| EP-0783283-A4 | METHOD AND COMPOSITIONS FOR TREATING IMPOTENCE | BAKER NORTON PHARMA (US) | 2000-05-10 | — | — | EP | disclosed |
| EP-0783283-A1 | METHOD AND COMPOSITIONS FOR TREATING IMPOTENCE | BAKER NORTON PHARMACEUTICALS, INC. (US) | 1997-07-16 | — | — | EP | disclosed |
| WO-1996034583-A1 | METHOD AND COMPOSITIONS FOR TREATING IMPOTENCE | BAKER NORTON PHARMACEUTICALS, INC. (US) | 1996-11-07 | — | — | WO | disclosed |
| US-5489610-A | TREATING CONDITIONS SUCH AS ANGINA PECTORIS, ISCHEMIC DISEASES, CONGESTIVE HEART FAILURE, CONTROLLING HYPERTENSION AND IMPOTENCE IN MALE PATIENTS | RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) | 1996-02-06 | — | — | US | disclosed |
| EP-0604642-A1 | SUSTAINED RELEASE ORGANIC NITRITE THERAPY | BAKER NORTON PHARMACEUTICALS, INC. (US) | 1994-07-06 | — | — | EP | disclosed |
| WO-1994001103-A1 | SUSTAINED RELEASE ORGANIC NITRITE THERAPY | BAKER NORTON PHARMACEUTICALS, INC. (US) | 1994-01-20 | — | — | WO | disclosed |